Bumetanide Articles
Sobi buys rights to novel neonatology treatment
16 January 2012
Four drugmakers to pay $124 million for submission of false claims to USA’s Medicaid
20 October 2009
Positive Verdict On Roche's Posicor From FDA Panel
10 March 1997
Mylan Product Launch
23 January 1995
DEMADEX APPROVED IN USA
13 September 1993
Showing 1-7 of 7 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Italy's pharma market slump set to continue, warns GlobalData
- Pfizer to split-off remaining 80% interest in Zoetis
